Mittag, AnnaHöra, ChristianOwesny, PatriciaKämpfe, Alexander David2024-06-162024-06-162022https://doi.org/10.60810/openumwelt-341https://openumwelt.de/handle/123456789/1949Zinc oxide nanoparticles (ZnO NP) are often used in the food sector, among others, because of their advantageous properties. As part of the human food chain, they are inevitably taken up orally. The debate on the toxicity of orally ingested ZnO NP continues due to incomplete data. Therefore, the aim of our study was to examine the effects of two differently sized ZnO NP (<50 nm and <100 nm primary particle size; 123â€Ì614 mikromol/L) on two model systems of the intestinal barrier. Differentiated Caco-2 enterocytes were grown on Transwell inserts in monoculture and also in coculture with the mucus-producing goblet cell line HT29-MTX. Although no comprehensive mucus layer was detectable in the coculture, cellular zinc uptake was clearly lower after a 24-h treatment with ZnO NP than in monocultured cells. ZnO NP showed no influence on the permeability, metabolic activity, cytoskeleton and cell nuclei. The transepithelial electrical resistance was significantly increased in the coculture model after treatment with _307 _mol/L ZnO NP. Only small zinc amounts (0.07â€Ì0.65 mikrog/mL) reached the basolateral area. Our results reveal that the cells of an intact intestinal barrier interact with ZnO NP but do not suffer serious damage. Quelle: Artikel1 Online-Ressourceonline resourceenghttp://rightsstatements.org/vocab/InC/1.0/ToxizitätZinkoxidWissenschaftlicher Artikel